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Microarray hybridization or antibody binding can be detected by many techniques, however, only a few are
suitable for widespread use since many of these detection techniques rely on bulky and expensive instruments.
Here, we describe the usefulness of a simple and inexpensive detection method based on gold nanoparticle labeled
antibodies visualized by a commercial, office desktop flatbed scanner. Scanning electron microscopy studies
showed that the signal from the flatbed scanner was proportional to the surface density of the bound
antibody–gold conjugates, and that the flatbed scanner could detect six attomoles of antibody–gold conjugates.
This detection system was used in a competitive immunoassay to measure the concentration of the pesticide
metabolite 2,6-dichlorobenzamide (BAM) in water samples. The results showed that the gold labeled antibodies
functioned comparably with a fluorescent based immunoassay for detecting BAM in water. A qualitative
immunoassay based on gold-labeled antibodies could determine if a water sample contained BAM above and
below 60–70 ng L21, which is below the maximum allowed BAM concentration for drinking water (100 ng L21)
according to European Union legislation.
Introduction
Microarray technology enabling mass-screening of numerous
analytes in a single assay1,2 is an attractive alternative to
conventional ELISA methods. One of the cornerstones of
protein microarray technology is the detection system, where
specificity, sensitivity, compatibility with a multiplex format,
and low instrument cost are desired properties.3 Radioactivity,
chemiluminescence, and fluorescence are widely used detection
markers for detecting interactions on microarrays, but hampered
by the high cost of detection systems. By contrast, a non-
expensive and relatively simple detection method using an
office flatbed scanner with a charge-coupled device (CCD) has
been described for detecting and quantifying the hybridization
of DNA fragments labeled with nanometer-sized gold parti-
cles.4
Immunoassays based on nanometer-sized gold particles have
proved to be adequately sensitive and reproducible for measur-
ing different antigens e.g. human placental lactogen (HPL) by
sandwich assays,5–8 with sensitivities comparable to ELISA
(5.4 pM HPL using 50 nm large gold particles as labels).
Compared to other particle labels such as polymer beads and
colloidal dyes, gold nanoparticles are more sensitive for
immunoassays.9
Since the gold nanoparticle is a robust and inexpensive label
we investigated the possibilities to use these for detecting
microarray-analyte interactions using a flatbed scanner. The
detection system was used to detect 2,6-dichlorobenzamide
(BAM), using a competitive immunoassay.10 BAM is a
breakdown product of dichlobenil which has been a widely used
pesticide but has been banned in many countries since
unacceptable levels of BAM have been found in drinking water
in Europe and the USA.
Experimental
Reagents and buffers
2,6-Dichlorobenzamide (BAM) was from Dr. Ehrenstorfer
GmbH, (Germany). Tween20, and bovine serum albumin (BSA
Fraction V) were from Merck (Germany). Gold sols (10 nm and
20 nm in diameter), and Tris-HCl were from Sigma (Denmark).
BAM hapten–ovalbumin–anthraquinone (BAM–OA–AQ) con-
jugates were from GEUS (Denmark) and prepared as described
by Bruun et al.10 Anti-BAM monoclonal antibodies (mAbs)
were generated by Statens Serum Institut (Denmark) as
described by Bruun et al.10–12
Water samples
Eight water samples from Danish waterworks were kindly
provided by Liselotte Clausen (E&R, Technical University of
Denmark, Denmark) and analyzed by GC-MS (Teknologisk
Institut, Denmark) and ELISA (GEUS, Denmark).
Labeling of mAbs to gold sols
Anti-BAM mAbs were conjugated to 10 nm and 20 nm gold
sols, essentially as described by Slot and Geuze.13 Briefly, 50
mL of mAb (100 mg mL21) were slowly added to 5 mL of gold
sol (pH 8.5). After vortexing for 5 min, 500 mL of 1% BSA was
added, followed by another 5 min of vortexing. The antibody–
gold sol (anti-BAM immunogold) solutions were sedimented by
centrifugation for 20 min at 4 °C at 8000g (20 nm gold sols) or
at 20 000g (10 nm gold sols). The supernatant was discarded
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and the anti-BAM immunogold conjugates were resuspended
by adding 500 mL of ice-cold Tris buffer (20 mM Tris, 0.1%
BSA, pH 7.4, Sigma). This washing procedure was repeated six
times and the anti-BAM immunogolds were adjusted to an
optical density of 5 at 520 nm (Ultrospec 3000, Amersham
Biosciences, Uppsala, Sweden) with Tris-sample buffer (200
mM Tris-HCl, 1.5 M NaCl, 1% BSA, pH 7.4).
Microarray printing and processing
BAM hapten–OA–AQ conjugates were diluted to 0.5 mg mL21
in 13 Genetix amine spotting buffer (Genetix, UK) and spotted
onto CSA microarray substrates (Cell Associates, TX, USA)
using a QArray microarray printer (Genetix, UK). Microarray
substrates were exposed to UV light at a wavelength of 254 nm
in a Stratalinker 2400 (Stratagene, USA) for 120 s and the
microarray substrates were incubated for 30 min in TBS block
buffer (20 mM Tris-HCl, 150 mM NaCl, 0.1% (w/v %) skim
milk powder, pH 7.5) followed by rinsing twice in Milli-Q
water for 5 min each.
Fluorescence BAM assay
27 mL of sample/standard were pre-incubated for 10 min with 3
mL of anti-BAM mAb in a final concentration of 100 ng mL21
in TBS sample buffer. 20 mL of each mixture was added to the
corresponding arrays and incubated for 1 h in a humid chamber
at either room temperature or at 4 °C. Following incubation, the
microarrays were washed for 10 min in TBST buffer (20 mM
Tris-HCl, 150 mM NaCl, 0.1% (v/v %) Tween20, pH 7.5) and
rinsed twice for 5 min in Milli-Q water and spin-dried. 20 mL of
Cy3 labeled goat anti-mouse antibody (1 mg mL21) (Sigma,
Germany) was added to each array and incubated for 1 h and
washed as above. Fluorescent Cy3 emission was acquired with
an ArrayWoRx CCD scanner (Applied Precision, WA, USA)
and quantified with the ArrayWoRx software.
Immuno gold BAM assay
Assay procedures were almost identical to the fluorescence
assay; however, anti-BAM immunogold mAbs were used
instead of unlabeled primary mAbs. After incubation, substrates
were only dipped into Milli-Q water for washing and spin-dried.
Processed arrays were scanned with a flatbed scanner (HP
Scanjet 5470c, Hewlett-Packard) with Dias illumination at 2400
dpi resolution, using the accompanying software (HP Pre-
cisionScan Pro, 3.13).
Scanning electron microscopy (SEM) settings
SEM images were generated using a LEO 1550 field emission
scanning electron microscope (Brock & Michelsen Instruments
A/S, Denmark). The acceleration voltage was set to 5 kV.
Results and discussion
Scanning electron microscopy (SEM) characterization of
microarrays spots bound with BAM immunogold
Binding assays were done by applying a buffered solution
containing gold nanoparticle labeled antibodies against BAM
(anti-BAM immunogold) onto microarrays printed with spots of
immobilized BAM. SEM analysis of microarrays after binding
assays showed highly packed grains of approximately 20 nm in
diameter distributed across the spot area (Fig. 1a). There was a
Fig. 1 (a and b) SEM Characterization of the immunogold assay. BAM
microarrays were incubated with a 10-fold dilution of anti-BAM im-
munogold for 3 h at room temperature and processed as described. (a) A
1 0003magnification of a BAM microarray spot. An artifact of presumably
precipitated salt grains is visible in the upper inside and outside area of the
spot. (b) The rectangle denoted in (a) shows a 50 0003 magnification
magnifying the spot borders. (c) Kinetics of anti-BAM immunogold binding
to immobilized BAM antigens. BAM microarrays were incubated with
5-fold or 20-fold dilutions of anti-BAM immunogold for between 20 min
and overnight. After processing, the microarrays were analyzed by SEM at
100 0003 magnification. Particle densities were counted manually. The
total particle count for each data-point was between 73 and 427. (d)
Correlation between the desktop scanner spot signals and the SEM
determined the number of bound particles mm2. Spots with different
amounts of bound gold anti-BAM conjugates as determined with SEM were
analyzed and quantified with the flatbed scanner. The scanner signal (Y-
axis) was expressed as mean value of all four spots per microarray was
plotted against the gold particle density (X-axis). Figure error bars represent
the standard deviation. Linear fit correlation coefficient = 0.976, line
equation: scanner signal = 12 3 particle density 2 400.
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clear difference in gold particle density between the spots and
the surroundings, suggesting that the binding was highly
specific to immobilized hapten (Fig. 1a). To evaluate the
binding kinetics of immunogold to the microarray spots,
microarrays with immobilized BAM hapten were incubated
between 15 min and overnight with solutions containing
different amounts of anti-BAM immunogold. The immunogold
binding rate to the microarray spots appeared to be linear up to
a density of 300 particles mm2 (Fig. 1c), which is similar to the
results obtained by previous studies.14,15 A 20-fold dilution of
anti-BAM immunogold was slower to reach the density of 300
particles mm2 compared to a 5-fold dilution. After overnight
incubation, an array spot density of around 500 particles mm2
incubation was established independent of the initial concentra-
tion of immunogold, suggesting this to be the maximum number
of gold particles that could be bound to the array spot surface.
This saturation is most likely due to steric hindrance since
decreasing particle size allowed for higher surface den-
sities.13–15 A gold particle density of 500 particles mm2 was
calculated to approximately cover 15% of the spot surface.
Spots with varying gold particle densities were used to
correlate the signal output from a 2400 dpi office flatbed
scanner to the SEM determined surface density of bound
immunogold particles. A linear correlation was found between
the scanner signal and the gold particle density, between the
lowest detectable density of 50 particles mm2 up to the
maximum density of 500 particles mm2 (Fig. 1d). The lowest
detectable density was defined as the gold particle density found
at 2 3 SD (standard deviation) of the scanner background
signal. Since the area scanned was approximately 70 000 mm2,
(4 circular spots of about 150 mm in diameter), it was calculated
that 6 3 10218 mol of anti-BAM immunogold conjugates could
be visualized with the flatbed scanner which is 6-fold more than
the 1 attomol of streptavidin coated gold particles that could be
detected with a CCD camera after silver enhancement.16
Comparison of immunogold and fluorescence assays
The reproducible binding of anti-BAM immunogold conjugates
to surface-immobilized BAM-haptens indicated that gold
particles could be a suitable detection label for microarrays. The
anti-BAM immunogold was compared to an identical fluores-
cence assay by exposing the respective antibody to a dilution
series of BAM. Both the immunogold assay and the fluores-
cence assay resulted in similar standard curves although the
IC50 values (Inhibition Concentration: analyte concentration
that gives 50% signal reduction) and detection limits were
slightly better for the fluorescence detection (Fig. 2).
Intra (replicas of assays) and inter-assay variation (assays
were performed on different days and different batches of
printed microarrays) of the immunogold assay was relatively
low (up to 17% as determined from triplicate experiments)
within the dynamic range. In comparison, the variance of the
fluorescence assay was generally lower than for the im-
munogold assays (intra assay variations of 1–11% and inter
assay of 4–16%).
Qualitative BAM immunogold assay
In order to increase the sensitivity of the immunogold assay, the
initial immunogold concentration was diluted 100 fold and the
reaction with the microarray was performed at 4 °C. These
conditions reduced the signal significantly resulting in a
qualitative assay that could detect BAM levels at cutoff levels of
50–100 ng L21 as determined by a dilutions series of BAM
(data not shown). Eight water samples was analyzed using the
BAM immunogold assay under these conditions and the results
showed samples containing 470 ng L21 BAM according to
GC-MS and ELISA analysis was recorded as BAM positive in
the test (no signal) while sample 8 provided a signal tested to
contain 60 ng L21 BAM. Thus, the cutoff concentration of the
BAM immunogold assay was estimated to be around 60–70 ng
L21 (320–370 pM) of BAM. The immunogold assay was
validated further by testing all the samples in a 20-fold dilution.
As expected, signals were obtained for all diluted samples, since
sample concentrations now were below the approximated
immunogold assay cutoff concentration of 60–70 ng L21 of
BAM. This detection level was below 100 ng L21, which is the
highest allowed BAM level in water according to current EU
legislations. The BAM immunogold assay used the same anti-
BAM mAb clone as described by Bruun et al.10 for the BAM-
ELISA, which had a practical detection limit of 20 ng L21.
Consequently, the immunogold assay is 3-fold less sensitive
than the corresponding ELISA, however, the immunogold assay
is experimentally simple to perform compared to the traditional
ELISA assay, which requires several washing and incubation
steps. Compared to dipstick pesticide assays17,18 that have total
assay times between 30 and 90 min, the immunogold assay as
performed here has a longer incubation time. However, the
immunogold assay is 8-fold more sensitive compared to the
dipstick assays, and thus applicable to be developed into other
and more sensitive screening applications. Furthermore, this
detection system could also be used in other analyte screening
applications based on different assay formats, e.g. sandwich
immunoassays, where high concentrations of immunogold
Fig. 2 Comparison of standard curves determined for the fluorescence and
immunogold assay BAM assays. In the fluorescence assay, BAM standards
ranging from zero to 10 000 ng L21, were mixed with 1 mg mL21 of
unlabeled anti-BAM mAbs followed by incubation with secondary Cy3-
labeled goat anti-mouse. The immunogold assay standard curves were
obtained similar to the fluorescence assay, however, using a 20-fold dilution
of anti-BAM immunogold and with overnight incubation at room
temperature. Standard curves and 4-parameter-logistic fits19 were generated
with Origin 6.1 (Originlab, USA). Fluorescence assays were performed in
triplicate while the immunogold assay was performed in nine replicates.
Figure error bars represent the standard deviation.
Table 1 Test of BAM in water samples
Sample 1 2 3 4 5 6 7 8
GC-MS/ng L21 340 230 210 180 150 130 70 60
ELISA/ng L21 350 290 190 170 150 110 80 60
Immunogolda 2 2 2 2 2 2 2 +
Controlb + + + + + + + +
a Each sample was tested in triplicate by BAM immunogold assay. (+)
indicates a spot signal (indicating that BAM levels were below the cutoff
level) and (2) that the signal could not be detected (indicating that BAM
levels were above the cutoff level). b The water samples were diluted 1:20
prior to analysis with the BAM immunogold assay.
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could be used and hence the assay time could be reduced
significantly.
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